Prediction of MIGS outcomes on second eyes using first eyes’ response

por Dickinson, Anna, Leidy, Luke, Nusair, Omar, Rachapudi, Sruti, Valenzuela, Tony, Ramulu, Pradeep, Mihailovic, Aleksandra, Yohannan, Jithin, Kaleem, Mona, Johnson, Thomas V., An, Jella
Publicado 2023

Trial to evaluate the immunogenicity and safety of a melanoma helper peptide vaccine plus incomplete Freund’s adjuvant, cyclophosphamide, and polyICLC (Mel63)

por Slingluff, Jr., Craig L, Petroni, Gina R, Chianese-Bullock, Kimberly A, Wages, Nolan A, Olson, Walter C, Smith, Kelly T, Haden, Kathleen, Dengel, Lynn T, Dickinson, Anna, Reed, Caroline, Gaughan, Elizabeth M, Grosh, William W, Kaur, Varinder, Varhegyi, Nikole, Smolkin, Mark, Galeassi, Nadejda V, Deacon, Donna, Hall, Emily H
Publicado 2021

Public engagement with genomics

por Middleton, Anna, Adams, Avery, Aidid, Hugbaad, Atutornu, Jerome, Boraschi, Daniela, Borra, Julian, Bircan, Tuba, Burch, Claudette, Costa, Alessia, Dickinson, Anna, Enticknap, Ann, Galloway, Catherine, Gale, Francesca, Garlick, Emma, Haydon, Em, Henriques, Sasha, Mitchell, Marion, Milne, Richard, Monaghan, Jack, Morley, Katherine I, Muella Santos, Milena, Olivares Boldu, Laura, Olumogba, Fifi, Orviss, Kate, Parry, Vivienne, Patch, Christine, Robarts, Lauren, Shingles, Sam, Smidt, Cindy, Tomlin, Ben, Parkinson, Sarah
Publicado 2023